PDB51 THE IMPACT OF NON-SEVERE HYPOGLYCEMIC EPISODES ON WORK PRODUCTIVITY AND DIABETES MANAGEMENT: A FOUR COUNTRY PERSPECTIVE  by Brod, M et al.
Abstracts A63
to be adherent than females (p = 0.05). CONCLUSIONS: American Diabetes Associa-
tion guidelines recommend statin therapy in every diabetes patients of age 40 years 
and above, regardless of their low-density lipoprotein level. Low adherence can result 
in the development of cardiovascular diseases, which can lead to increase in outpatient 
and emergency room visits and hence, increase in the health care costs. Adherence to 
statins was suboptimal among this study population. This presents an increased risk 
of developing cardiovascular diseases, which can lead to increases in the health care 
costs for this self-insured university.
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OBJECTIVES: To examine the effect of a community pharmacy based medication 
therapy management program (MTM) on patient outcomes over one year. METHODS: 
A one year, pre-post longitudinal study. Patients served as their own controls. Com-
munity pharmacists provided MTM services to the City of Toledo employees and their 
dependents with diabetes. Employees were seen every 3 months at one of seven par-
ticipating pharmacy sites. Participants received a 3 month supply of medications at 
the cost of one co-pay as an incentive. Data collected: quality of life scores (SF-36), 
self-reported adherence (Modiﬁed Morisky scale of 1–5, 1 being always adherent and 
5 being never adherent), number of sick days, and patient satisfaction with services 
(Likert scale of 1–5, 1 being highly unsatisﬁed and 5 being highly satisﬁed). Data was 
analyzed using SPSS v 16.0 for one year using descriptive statistics and Friedman tests. 
RESULTS: One hundred one employees enrolled at baseline. Patients had improved 
scores on physical functioning, role physical, bodily pain, and social functioning. The 
physical component summary remained roughly the same. Mental component scores 
decreased, but not signiﬁcantly. Self-reported adherence improved signiﬁcantly from 
3.83 to 2.68 (p < 0.005) over 12 months. There was a decrease in the use of sick days 
from 1.13 ± 5.32 at baseline to 0.09 ± 0.39(p = 0.368) at the end of the study. Patients 
who reported using sick days at baseline on average reported less use of sick days 
over one year. Overall patient satisfaction signiﬁcantly increased from 3.26 to 4.52 
(p < 0.001) over 12 months. Experience with the pharmacist and experience with 
pharmacy services were the highest rated items. CONCLUSIONS: Improved quality 
of life and adherence can help increase productivity of employees and can help reduce 
costs for employers by reducing disease-related missed days of work. Employers 
looking to save costs and improve productivity can utilize the services provided by 
pharmacists.
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OBJECTIVES: Since pediatric growth disorders such as Growth Hormone Deﬁciency 
(GHD) and Idiopathic Short Stature (ISS) might affect subjective wellbeing and func-
tioning, treatment outcomes should include assessment of quality of life (QoL). The 
multinational QoLISSY project aims at developing simultaneously in 5 countries, a 
targeted instrument to measure outcomes in short stature children in three age groups 
(4–7, 8–12, & 13–18 yrs.). METHODS: The project follows international instrument 
development guidelines and uses focus groups, cognitive interviewing, and pilot- and 
ﬁeld testing. Per country, 24 children (height <−2 SDS) and one of their parents were 
recruited into focus groups according to age group (8–12 and 13–18 yrs.), gender, 
diagnosis (ISS/GHD) and GH-treatment (treated and non-treated). Statements derived 
from focus groups were used to formulate items which were subsequently presented to 
24 child-parent pairs per country for cognitive debrieﬁng. Additional focus groups with 
parents of very young children were also conducted. RESULTS: The focus groups 
included 96 children (age 8–18), 126 parent participants, as well as 38 parents of young 
children (4–7 yrs.). All material was transcribed and relevant passages reduced to state-
ments (1800 child, 2500 adult) which were further reduced to items (170 child, 209 
adult). CONCLUSIONS: This process provided rich material for further analysis and 
a sound basis for pilot testing. Short stature appears to be a main focus of attention for 
children and their parents, with teasing and bullying as frequent experiences. Some 
inter-individual and cross-cultural differences in concepts were found, suggesting a 
more complex model for understanding wellbeing and functioning than ﬁrst envi-
sioned. These preliminary results showed that a comprehensive taxonomy of psycho-
logical outcomes is needed as well as more research regarding the effects of psychological 
and medical treatment on quality of life of short stature children and their families.
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OBJECTIVES: Prior to use in an international study, the PedsQL™ 3.2 Diabetes 
Module consisting of 5 reports (Teen report, Adult report, Child report, Parent report 
for teens, Parent report for children) underwent linguistic validation into 10 languages. 
A rigorous methodology was conducted to ensure conceptual equivalence, cultural 
relevance and appropriateness of formulations across the 3 age categories. This 
involved forward / backward translations and testing on a sample of the 3 age groups. 
29 out of 32 items being identical in the original, the aim of our study was to inves-
tigate if this was the case in the translations, determine a potential pattern should 
there be differences and make recommendations on the basis of the results. METHODS: 
This investigation was carried out as follows: 1) Comparison of the 29 identical items 
across the Teen, Adult and Child reports in the 10 translations; 2) identiﬁcation of 
differences across the three reports; and 3) determination of a pattern in the differ-
ences. RESULTS: First results indicate that language versions are relatively similar 
across the 3 reports with few differences and no identiﬁable pattern. The differing 
formulations across age groups are not the same across translations. Differences are 
not linked to the translation of technical terms, but found in items on general symp-
toms. CONCLUSIONS: The similarities across the 3 age-speciﬁc forms for the 10 
languages seem to indicate the universal and intergenerational acceptability of the 
original concepts and their formulations. Given the differences without identiﬁable 
pattern across age categories in some languages however, it is recommended to test 
the understanding of each item through cognitive debrieﬁng on a sample of each age 
group despite the use of identical formulations in the original. This will ensure appro-
priate comprehension across age groups and translations and facilitate international 
comparison and pooling of data.
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OBJECTIVES: To examine how obesity and quality of life (QOL) affect medical (MC) 
and lost productivity costs (LPC) in U.S. adults with diabetes. METHODS: A cross 
sectional study design was applied using the 2003–2006 Medical Expenditure Panel 
Survey data. The study population consisted of patients aged 18–64 with diabetes, 
but without immunodeﬁciency, malignancy, kidney dialysis, or underweight. Diabetic 
patients’ QOL were classiﬁed as low (≤25%), medium ( > 25%- < 75%), and high 
(≥75%) based on quartiles of the SF-12 physical component scale(PCS-12) and mental 
component scale(MCS-12) respectively. Patients’ BMI was classiﬁed as normal, over-
weight, and obese. Diabetic complications included heart disease, stroke, retinopathy, 
neuropathy, and nephropathy. MCs were estimated using a generalized linear regres-
sion model with log link and gamma distribution after adjusting for patient charac-
teristics and comorbidities. LPC were calculated based on missed working days due 
to illness and average hourly wage using a two part model for working adults. All 
costs were converted to 2008 U.S. dollars. RESULTS: The study identiﬁed 3,621 
diabetic patients. Patients with low PCS-12 had more complications, compared to 
those with high PCS-12 (17.0% vs. 4.4%). A similar trend was also observed for 
MCS-12 (11.8% vs. 8.2%). In general, patients with lower PCS-12 had higher MC 
($12,203 in low-QOL vs. $3,172 in high-QOL) and LPC ($1,632 in low-QOL vs. 
$293 in high-QOL). A similar trend was found in the relationship between MCS-12 
and both costs, but this relationship was weaker than that of PCS-12. Among patients 
with medium to high PCS-12, obese patients had higher MC and LPC than normal 
or overweight patients. CONCLUSIONS: Lower levels of QOL were associated with 
a higher economic burden on diabetic patients, especially the physical QOL compo-
nent. Among diabetic patients with higher levels of physical QOL that are less con-
founded by disease severity and complications, the impact of obesity on economic 
burden was observed.
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OBJECTIVES: The objective of the study was to understand of the impact of diabetes-
related non-severe hypoglycemic episodes (NSHE’s) on work productivity and diabetes 
management. METHODS: A web-based survey was developed based on literature, 
expert input and 68 patients participating in focus-group or individual interviews. 
Persons with self-reported diabetes in US, France, Germany, and UK participated in 
the survey. NSHE’s were classiﬁed as occurring in the past month, either daytime 
(while at work or not at work) or during sleep. RESULTS: A total of 6756 persons 
were surveyed of whom 972 (14.4%) worked for pay and had a NSHE. The mean 
age of the sample was 41.3 ± 13.5. There were no signiﬁcant country differences for 
% on insulin vs. oral or % type1 vs. type 2 subjects. Fifty-nine percent of type 1 
subjects (range 50.7% in France – 70.9% in US, p = 0.001) and 34.8% of type 2 
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subjected (range 31.4% in US −38.1% in France, p = 0.827) reported having a NSHE 
at least weekly. Diabetes management was impacted as 20.9% of insulin dependent 
subjects reported decreasing their normal insulin dose on average 18.7 units per day 
over 3.2 days. Further, a mean of 7.0 extra blood glucose tests were conducted in the 
week following their last NSHE. For those whose last NSHE was at work (n = 483), 
work productivity was impacted with 28.6% reported missing work (e.g., leaving 
early) due to this NSHE. For those whose last NSHE occurred during the day but 
outside of work (n = 368), 18.2% of respondents reported work absenteeism due to 
this NSHE. For those whose last NSHE was during sleep (n = 121), 16.5% of respond-
ents reported subsequent work absenteeism. CONCLUSIONS: NSHE’s have a con-
siderable impact on work loss productivity across these countries. The seriousness of 
NSHEs may be underestimated and should be considered an important part of diabetes 
management.
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OBJECTIVES: Weight management and exercise are key self-management treatments 
for patients with type 2 diabetes mellitus (T2DM). This study examined the associa-
tion between trying to lose weight or exercising regularly and health-related quality 
of life among individuals with and without T2DM. METHODS: Respondents to the 
US Study to Help Improve Early evaluation and management of risk factors Leading 
to Diabetes (SHIELD) baseline survey reported if they had tried to lose weight during 
the last 12 months and if they currently exercised regularly for > 6 months. Respond-
ents also completed the SF-12 quality-of-life survey 1 year later. The Physical Com-
ponent Score (PCS) and Mental Component Score (MCS) of the SF-12 were computed, 
and differences between T2DM respondents (n = 2419) and respondents with no 
diabetes mellitus (n = 6750) were tested using t-tests. Linear regression models adjusted 
for age, gender, race, education, household income, body mass index (BMI), and 
diabetes status. RESULTS: Among T2DM respondents, 71% reported trying to lose 
weight in the past 12 months and 20% reported exercising regularly for >6 months, 
compared with 64% of respondents without diabetes reporting trying to lose weight 
and 25% exercising regularly. After adjusting for demographics, BMI and diabetes 
status, trying to lose weight was not associated with higher PCS scores (p = 0.87), but 
was independently associated with higher MCS scores (p = 0.01) in the subsequent 
year. After adjustment, exercising regularly was signiﬁcantly associated with higher 
subsequent PCS and MCS scores (p < 0.001). CONCLUSIONS: Respondents with 
T2DM who reported exercising regularly had signiﬁcantly better physical quality of 
life, compared with respondents without diabetes who exercised regularly. Respond-
ents with T2DM who reported trying to lose weight or exercising regularly for > 6 
months had better mental quality of life, compared with respondents without diabetes 
who tried to lose weight or exercised.
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OBJECTIVES: Hypoglycemia can be a critical issue in T2DM management and may 
impact patients in many ways. Using published data we aimed to identify and evaluate 
the impact of these events on patient quality of life and treatment satisfaction. 
METHODS: A systematic review of literature databases (no date limit, 1066 citations 
retrieved) and conference proceedings (2007–2009) was carried out. Studies reporting 
the effect of hypoglycemic events on quality of life or treatment satisfaction using 
generic or hypoglycemia-speciﬁc measures were included. RESULTS: Seventeen studies 
were identiﬁed that provided useful information for the study question, mostly in 
European populations. All studies relied on self-reporting of hypoglycemic episodes, 
with heterogeneity in methods and classiﬁcation used. Seven of eight studies reported 
negative correlations between reporting (and in three studies also severity) of hypogly-
cemic events and QoL measured using the EQ-5D instrument: the difference between 
patients reporting and not reporting events (summary score: 0.08–0.20 on 0–1 scale; 
VAS: 4.2–11.3 on 0–100 scale) suggests clinical importance. No correlation was 
observed in the sole study examining insulin-treated patients. Four additional studies 
reported correlations between experience of hypoglycemia and lower QoL scores using 
other generic instruments; three studies reported lower scores on the Treatment Sat-
isfaction Questionnaire for Medication in oral antidiabetics (OAD)-treated patients 
experiencing hypoglycemia. The results of three studies indicated that occurrence and 
severity of hypoglycemia were associated with higher Worry scores in the Hypoglyc-
emia Fear Survey-II in OAD-treated patients, with one study further identifying this 
as a clinically important difference when related to treatment satisfaction. CONCLU-
SIONS: This review identiﬁes a body of data which describe the relationship between 
hypoglycemia and patient-reported outcomes. Despite variation in methods and 
instruments used, the results of these studies indicate hypoglycemic events have a 
notable and clinically important impact on quality of life in T2DM patients, including 
those treated with OADs.
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OBJECTIVES: A central Texas HMO plan implemented a pharmacist-led diabetes 
medication management program (MMP) offering co-pay waivers. Medication adher-
ence and diabetic control were compared between patients enrolled in the MMP vs. 
control patients. Health care costs and utilization were also compared. METHODS: 
Patients were enrolled in the MMP if they had baseline A1C levels >7.5% and continu-
ous enrollment throughout the study period (“rolling” enrollment from August 
2006-July 2008). The enrollees and controls were matched 1:1 by age, gender, baseline 
A1C, and Charlson comorbidity index (CCI). A1C and adherence (Medication 
Possession Ratio (MPR)) were measured one year before and after implementation. 
Paired t-tests compared the changes in MPR and A1C. Health care costs and 
utilization were analyzed by year, group, types of service, and diabetes-related vs. 
all-cause claims. RESULTS: A total of 136 patients were enrolled in the MMP for at 
least 1 year (46 of those enrolled for two years). A1C decreased 5% in controls and 
12% in MMP patients; the difference between groups was statistically signiﬁcant (P 
< 0.001). The MPR for oral hypoglycemics increased from 76% to 81% one year after 
in MMP enrollees, whereas MPR remained at 76% in controls; the difference was not 
statistically signiﬁcant (P = 0.159). The baseline health care costs were 23% higher in 
MMP enrollees than controls, possibly due to a few outliers. After one year, the 
average per member per month (PMPM) cost increased by 21% and 14% in MMP 
and control groups, respectively; the larger increase was mainly attributable to growth 
in diabetes-related drug and outpatient claims. Over two years post-implementation, 
the average MMP PMPM increased by 2%, while the average control PMPM 
increased by 14%. CONCLUSIONS: The medication management program improved 
patients’ outcomes. Although one-year costs increased, the slowdown of costs over 2 
years in MMP patients compared to controls indicates potential savings over the long 
term.
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OBJECTIVES: To increase our understanding of the impact of diabetes-related non-
severe hypoglycemic episodes (NSHE’s) on patient functioning and diabetes manage-
ment. METHODS: A web-based survey of adults with diabetes (US, France, Germany, 
and UK). NSHE’s were classiﬁed as occurring in the past month, either during the day 
or during sleep (nocturnal). RESULTS: 6,756 persons with diabetes were surveyed, 
2,430 had at least one NSHE in the past month. The mean age was 46.1 ± 14.8 (range 
18–90), 1378 (56.7%) were female and average duration of diabetes was 12.8 ± 11.8 
years (range 0.08–72.8). 89.2% (n = 2,167) reported at least 1 daytime NSHE and 
44.7% (n = 1086) had at least 1 nocturnal NSHE. In the past month, $45.64 out-of-
pocket was spent on foods, glucose products, transportation, etc. to either prevent or 
cope with these NSHE’s. For daytime NSHE’s, the average amount of time respond-
ents reported not functioning at their usual level was 9.0 ± 24.9 hours if the NSHE 
occurred while they were active and 12.4 ± 62.3 hours for NSHE occurring while not 
active. On average, 8.3 extra blood glucose monitoring test strips were used and 
insulin was decreased on average by 10 units over the following 6 days. For sleep 
related NSHE’s, on average, it took 1.4 ± 1.9 hours to return to sleep with 15.6% 
not being able to go back to sleep at all after the episode. 81.9% (n = 889) reported 
being tired the following day as a result of the event. Sleep related NSHE’s resulted 
in on average 11.4 ± 84.1 extra blood glucose monitoring test strips used and insulin 
was decreased on average by 13.8 units over the following 6 days. CONCLUSIONS: 
NSHE have a considerable impact on daily functioning as well as add to the ﬁnancial 
burden of living with diabetes. The seriousness of NSHE’s may be underestimated and 
should be considered an important part of diabetes management.
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OBJECTIVES: We estimated rates of diabetes care indicated services in adult type 2 
diabetics in a state Medicaid population and associations between receipt of services 
in Fee-For-Service (FFS); Care Management (CM), i.e., fee-for-service plus care coor-
dination; and Managed Care (MC) subprograms. METHODS: A retrospective cohort 
analysis of Indiana Medicaid 2006 and 2007 eligibility, claims, and encounter ﬁles 
was conducted. Persons 18 to 64 y/o, with diabetes based on ICD-9 codes or NDC 
codes, and ≥12 months continuous eligibility in one subprogram were included. Exclu-
